Cargando…

P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre

Detalles Bibliográficos
Autores principales:	Petersen, L., Gibson, A., Gerat, K., Kinch, L., Elegbede, A., Brennan, K., Dean, M., Bebb, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	P32 Management of Lung Cancer in the Era of Covid-19 - Screening and Diagnosis of Lung Cancer during Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523139/ http://dx.doi.org/10.1016/j.jtho.2021.08.415

Ejemplares similares

P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution
por: Teixeira, C.H., et al.
Publicado: (2021)

P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
por: Araujo, A., et al.
Publicado: (2021)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

P34.01 6-Weekly vs 3-Weekly Pembrolizumab – Toxicities and Tolerance in The COVID-era
por: Douglas, C., et al.
Publicado: (2021)

P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK
por: Aujayeb, A.
Publicado: (2021)

P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021)

P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
por: Tsukazan, M.T., et al.
Publicado: (2021)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study
por: Ospina Serrano, A.V., et al.
Publicado: (2021)

P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study
por: Patel, A., et al.
Publicado: (2021)

FP06.02 The Impact of The COVID-19 Pandemic on New Diagnoses of Lung Cancer: A 3-Year Review of an Irish Cancer Centre
por: Carroll, H., et al.
Publicado: (2021)

P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient
por: Aujayeb, A.
Publicado: (2021)

Initial results of the National Lung Cancer Screening Trial
por: McLoud, T.C.
Publicado: (2011)

NELSON lung cancer screening study
por: Zhao, Ying Ru, et al.
Publicado: (2011)

Lung cancer screening: rationale and background
por: Diederich, S.
Publicado: (2011)

EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
por: Rizzolo, A., et al.
Publicado: (2022)

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis
por: Liu, Jie, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China
por: Li, Tao, et al.
Publicado: (2023)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer
por: Nezami, Nariman, et al.
Publicado: (2022)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer
por: Mansur, Arian, et al.
Publicado: (2023)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

FP06.03 COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic?
por: Tsukazan, M.T., et al.
Publicado: (2021)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Preventing the Spread: A Comprehensive Cancer Center’s Journey to Prevent the Spread of Coronavirus Disease (Covid-19) During the 2020 Pandemic
por: Carraway, Stephanie, et al.
Publicado: (2021)

Universal COVID-19 screening at hospitals in a large Canadian health region
por: Garrod, Matthew, et al.
Publicado: (2023)

CRT-200.02 National Trends of Structural Heart Disease Interventions From 2016 to 2020 in the United States and the Associated Impact of COVID-19 Pandemic
por: Maraey, Ahmed, et al.
Publicado: (2023)

Impact of the COVID‐19 Pandemic on the Employment of Canadian Young Adults With Rheumatic Disease: Findings From a Longitudinal Survey
por: Jetha, Arif, et al.
Publicado: (2021)

Impact of COVID-19 on healthcare-associated infections in Canadian acute-care hospitals: Interrupted time series (2018–2021)
por: Silva, Anada, et al.
Publicado: (2023)

Is investigation of patients with haemoptysis and normal chest radiograph justified?
por: Thirumaran, M, et al.
Publicado: (2009)

Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial
por: Ishida, Takashi, et al.
Publicado: (2011)

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer
por: Baldwin, D R, et al.
Publicado: (2011)

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
por: Lüchtenborg, Margreet, et al.
Publicado: (2014)

Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3p7ss5n5ifoieplpq59mm5r130